Analyst Ratings for ADC Therapeutics (ADCT)
ADCT Rating Summary
ADCT Price Target Summary
- Highest: $10.00 (Guggenheim)
- Lowest: $5.00 (RBC Capital)
- Average: $7.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$7.75 (+88.6%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 66%
Rating Score: 6.2 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/8/2024 | Stephens » Updated 2/24/2025 |
Sudan Loganathan | New Coverage | Overweight (N/A) |
8.00 (6.00) |
3.20 (4.11) |
28.44% | Details |
| 5/30/2024 | Cantor Fitzgerald | Eric Schmidt | New Coverage | Overweight (N/A) |
N/A (N/A) |
3.33 (4.11) |
23.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
